Accretive Health
AH
AH was delisted on the 14th of March, 2014.
85 hedge funds and large institutions have $476M invested in Accretive Health in 2013 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 31 increasing their positions, 26 reducing their positions, and 23 closing their positions.
113% more call options, than puts
Call options by funds: $3.33M | Put options by funds: $1.56M
19% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 26
2% more capital invested
Capital invested by funds: $469M → $476M (+$7.41M)
14% less funds holding
Funds holding: 99 → 85 (-14)
57% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 23
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.6M |
| 2 |
CII
CR Intrinsic Investors
Stamford,
Connecticut
|
+$5.59M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.65M |
| 4 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
+$3.54M |
| 5 |
NTC
North Tide Capital
Boston,
Massachusetts
|
+$3.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NRC
North Run Capital
Boston,
Massachusetts
|
-$19.1M |
| 2 |
SC
Sageview Capital
Greenwich,
Connecticut
|
-$9.65M |
| 3 |
GC
GMT Capital
Atlanta,
Georgia
|
-$7.36M |
| 4 |
Canada Life
Winnipeg,
Manitoba, Canada
|
-$5.36M |
| 5 |
Millennium Management
New York
|
-$2.14M |
AH Hedge Fund Activity: Q4 2013 in Review
85 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Accretive Health (AH) for Q4 2013, worth a combined $476M — up 1.6% from $469M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of AH and 10 opened new positions — a net loss of 13 holders — while 26 trimmed existing stakes and 31 added.
The largest buyer was Fidelity Investments, adding an estimated $21.6M. The largest seller was North Run Capital, exiting entirely with an estimated $19.1M sold.
- 85 institutional investors held Accretive Health (AH) as of Q4 2013, down from 99 in Q3 2013.
- Funds reported $476M of Accretive Health stock for Q4 2013, up 1.6% quarter-over-quarter.
- 10 funds opened new Accretive Health positions in Q4 2013 and 23 closed out, a net change of -13 holders.
- The largest Accretive Health buyer in Q4 2013 was Fidelity Investments, an estimated $21.6M added.
- The largest Accretive Health seller in Q4 2013 was North Run Capital, an estimated $19.1M sold.
Based on aggregated 13F filings for Q4 2013.